BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Mallinckrodt
Covington
Baxter
McKinsey
Daiichi Sankyo
Colorcon
Queensland Health
Novartis
Cipla

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,597,681

« Back to Dashboard

Summary for Patent: 8,597,681
Title:Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans
Abstract: Methods for producing stabilized solid dosage form pharmaceutical compositions are provided. In particular, methods for preparing protected granules containing morphinans, and solid dosage form pharmaceutical compositions produced using the morphinan-protected granules are provided.
Inventor(s): Park; Jae Han (Olivette, MO), Eisenhauer; Tiffani (Columbia, IL), Dhanarajan; Anish (Metuchen, NJ), Gupta; Vishal K. (Hillsborough, NJ), Overholt; Stephen (Middlesex, NJ)
Assignee: Mallinckrodt LLC (Hazelwood, MO)
Application Number:13/166,770
Patent Claim Types:
see list of patent claims
Composition; Compound; Process; Formulation; Dosage form;

Drugs Protected by US Patent 8,597,681

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Mallinckrodt Inc XARTEMIS XR acetaminophen; oxycodone hydrochloride TABLET, EXTENDED RELEASE;ORAL 204031-001 Mar 11, 2014 DISCN Yes No ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 8,597,681

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,980,319 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans ➤ Subscribe
9,198,861 Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 8,597,681

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2011345329 ➤ Subscribe
Canada 2822553 ➤ Subscribe
China 103402499 ➤ Subscribe
European Patent Office 2654727 ➤ Subscribe
Japan 2014500315 ➤ Subscribe
Japan 2015193668 ➤ Subscribe
Japan 5897036 ➤ Subscribe
South Korea 101748906 ➤ Subscribe
South Korea 20140021992 ➤ Subscribe
Mexico 2013007057 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Colorcon
Boehringer Ingelheim
Covington
Federal Trade Commission
AstraZeneca
Mallinckrodt
US Army
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot